Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 07:37:06 2026-09-09 am EDT			5-day change	1st Jan Change
57.58 ^EUR	-1.83%		-3.92%	-9.37%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.49B		BBB
ELI LILLY AND COMPANY	1,002B		A
JOHNSON & JOHNSON	649B	-	BBB	-	-
ABBVIE INC.	440B		AAA		-
ROCHE HOLDING AG	346B		AA
NOVARTIS AG	263B		AAA
ASTRAZENECA PLC	250B		A
AMGEN INC.	213B		A
NOVO NORDISK A/S	201B		BBB
GILEAD SCIENCES, INC.	182B		AA
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	134B		AA
BRISTOL-MYERS SQUIBB COMPANY	132B		A
SANOFI	104B		A
GSK PLC	97.52B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	69.7B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	59.65B		AA
BAYER AG	56.46B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	44.85B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.84B		-
Average	222.34B		AA
Weighted average by Cap.			AA